MedTrace Logo

Submassive Pulmonary Embolism Experience With EKOS

NCT02926742 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2016-10-06

No results posted yet for this study

Summary

This single site study evaluates the efficacy of ultrasound accelerated thrombolysis using EKOS Endovascular Device with a standard infusion of thrombolytics for treatment of PE

Conditions

Interventions

DEVICE

EkoSonic Endovascular System

Ultrasound catheter-directed thrombolysis.

Sponsors & Collaborators

  • EKOS Corporation

    collaborator INDUSTRY

  • Krishna Mannava, MD, FACS, RPVI

    lead OTHER

Principal Investigators

  • Lisa K Stevens, MSN · Fairfield Medical Center

  • Krishna Mannava, MD · Fairfield Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926742 on ClinicalTrials.gov